Enjoy complimentary customisation on priority with our Enterprise License!
The 3D bioprinting market size is forecast to increase by USD 3.56 billion, at a CAGR of 26.06% between 2023 and 2028. The growth of the market depends on several factors, including the rising cost efficiency and enhanced productivity, the advancements in technology, and the increased demand for personalized or customized orthopedic devices. Challenges such as high initial costs to set up a 3D printing facility, the inability of researchers to combine vascular supply in printed tissues and organs, and the limited availability of suitable biomaterials might hamper the growth of the market. Nevertheless, trends such as developments in scaffold-free bioprinting, bio-fabrication of complex tissues, and the rising focus on R&D of 3D bioprinting will boost the growth of the market. It also includes an in-depth analysis of market trends and analysis, market growth analysis and challenges. Furthermore, the report includes historic market data from 2018 - 2022.
To learn more about this report, View Report Sample
The market is witnessing significant growth due to the increasing demand for organ donors and the aging population. This technology holds immense potential in creating functional tissues and organs for medical treatments, including respiratory epithelium for respirators and ventilators. Companies like Viscient Biosciences are leading the way in biotherapeutic applications, using 3D bioprinting to create complex tissues such as nasopharyngeal swabs. Stratasys, a key player in the market, utilizes inkjet-based, laser-assisted, and extrusion-based 3D printers to create bioprinting materials. These materials are essential for the production of natural tissues, including artificial skin, hair follicles, and drug delivery systems for drug molecules. The process control in 3D bioprinting is crucial to prevent potential damage to the tissues being printed. The market is expected to grow further as research continues in the development of bioprinting materials and the application of 3D bioprinting in drug development and organ transplants. Tissue engineering and drug delivery systems are two major areas of focus in the market, with magnetic levitation technology being explored for its potential in creating precise and uniform tissue structures. Overall, the 3D bioprinting market holds immense promise in revolutionizing medical treatments and organ transplants.
Market expansion is notably fueled by advancements in 3D bioprinting technology, characterized by ongoing improvements in bio-ink formulations, printing methods, and tissue engineering strategies. These enhancements facilitate the creation of intricate tissue structures, revolutionizing regenerative medicine. Novel bio-ink formulations enhance cell survival and tissue fusion, enabling personalized structures for patients. Enhanced printing methods, utilizing multiple printheads, enable precise deposition of various cell types and materials, yielding intricate tissue constructs.
Further, innovative tissue engineering methods, such as bioprinting on pre-pasteurized substrates, offer promising options for robust tissue fabrication. Consequently, 3D bioprint technology fosters market growth, pushing boundaries in regenerative medicine and personalized healthcare. Expectations for substantial market expansion remain high, driven by these transformative advancements.
The fabrication of complex tissues is a primary trend in the market share. The focus on fabricating complex tissues and multi-organ complexes is a prominent trend in the market. To create functioning tissues with complex structures, researchers are investigating the simultaneous printing of several cell types, extracellular matrix, and growth hormones.
Moreover, the development of multi-organ complexes and complex tissues that can be printed holds great promise for the future of personalized healthcare and regenerative medicine. In view of that fact, this trend is anticipated to have a strong impact on the market growth and trends over the forecast period and will be instrumental in its growth.
The inability of researchers to combine vascular supply in printed tissues and organs is a major challenge in the market. Although the market has witnessed breakthroughs over the years, it is far from bioprinting a fully functional organ or tissue for transplant. The researchers are successful in bioprinting parts of an organ or tissue that has cells fully capable of performing their dedicated functions. However, they have not been able to combine vascular veins in the printed organs, though they can be printed separately. The bioprinted product needs the vascular vein network and the necessary blood flow in it to work.
However, without the vascular system, the thickness of the tissue is limited. Growth in the focus market would be limited until an intact organ has been developed and readiness for transplantation is achieved. It does not envisage that this technology will be commercially available to end users in the future. Consequently, it is expected that a challenge to the growth of the market in focus over the forecast period will be researchers' failure to combine blood vessel supply for printing tissues and organs.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The human tissue and organ generation segment is estimated to witness significant growth during the forecast period. The market is driven by the aging population's increasing demand for advanced medical treatments. Innovations like biotherapeutics and artificial organs propel market growth. Companies like Viscient Biosciences and Stratasys pioneer inkjet-based and laser-assisted bioprinting technologies, enabling precise drug delivery and organ fabrication. However, challenges like ensuring proper respiratory epithelium integration and preventing potential damage during the printing process persist. Despite these hurdles, 3D bioprinting holds immense promise in revolutionizing healthcare by offering personalized medical solutions and addressing critical organ shortages.
Get a glance at the market contribution of various segments View the PDF Sample
The human tissue and organ generation segment showed a gradual increase in the market share of USD 251.10 million in 2018. The market share growth by the human tissue and organ generation segment will be significant during the forecast period. Human tissue and organ generation can reduce the waiting period for patients who need organ donors. The other benefit of using 3D-bioprinted organs is that the chances of the patient's body rejecting the implant are reduced to a bare minimum. Organ implants from donors are often rejected by the patient's body leading to complications post-implantation. The demand for 3D bioprinting in the Human tissue and organ generation application is expected to increase and hence drive the growth of the market in focus during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America accounted for the largest revenue share of the global market in 2023. The US and Canada are the significant revenue contributors to the market in focus in North America. The growth of the market in focus in the region can be attributed to improved healthcare infrastructure, high adoption of 3D bioprinting technologies in healthcare facilities, and the presence of established companies.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
Revolutionizing Medical Treatments and Organ Transplants with Advanced Technologies 3D bioprinting is an emerging field that utilizes 3D printing technology to create living tissues and organs using biocompatible materials and living cells. The market for 3D bioprinting is witnessing significant growth due to the aging population's increasing demand for organ donors and advanced medical treatments. Companies like Viscient Biosciences are leading the way with innovations in respiratory epithelium, Nasopharyngeal swab, and biotherapeutics. Stratasys' inkjet-based technology and Magnetic levitation systems are paving the way for the 3D printing of complex structures like vascular muscle and human cell regeneration. Bioprinting materials, such as biomaterials and natural tissues, are essential for creating living cells and tissues. Process control and potential damage to living cells during bioprinting are critical challenges that require skilled professionals' expertise. Technological advancements in drug delivery, toxicity screening, and bioengineering are addressing these challenges.
Further, 3D bioprinting holds immense potential for medical treatments, including drug development, artificial skin, hair follicles, and organ transplants. Patent analysis and buying behaviour studies are crucial for understanding the market dynamics and future growth opportunities. The market for 3D bioprinting is expected to grow significantly due to the potential applications in medical pills, tissue and organ engineering, and drug development. In the field of regenerative medicine, advancements in bioassay and 3D-printed skin for bone grafts are enhanced by innovations in extrusion based technologies and cell viability assessments, while research into vascular muscle printing and immunosuppressants aims to improve the effectiveness of donor organs transplants, considering the roles of metals and plastics in developing new materials for these applications and understanding patient buying behavior for these emerging treatments.
|
Industry Scope |
|
|
Report Coverage |
Details |
|
Page number |
174 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 26.06% |
|
Market growth 2024-2028 |
USD 3.56 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
21.6 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 33% |
|
Key countries |
US, China, Germany, Canada, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
3D Bioprinting Solutions, 3D Systems Corp., Advanced Solutions Inc., Aspect Biosystems Ltd., BICO Group AB, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal Inc., Foldink, GE Healthcare Technologies Inc., Hangzhou Jienuofei Biotechnology Co. Ltd., Inventia Life Science Pty Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio Inc., regenHU Ltd., and ROKIT Healthcare Inc. |
|
Market dynamics |
Parent market analysis, Market forecast, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Solution
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
